Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
VALEANT Pharmaceuticals International Inc slashed its 2016 forecasts on Tuesday, as its new chief executive said he would focus on rebuilding the reputation of a "distracted organisation" with a debt-loaded balance sheet.
The maker of toenail fungus cream Jublia and anti-...